Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
lorbas's Profile
Displaying 201-250 of 1057 result(s).
CYDY CytoDyn Inc
09/01/2020 7:12:06 AM
CD-12 trial updated: https://clinic (10)
CYDY CytoDyn Inc
09/01/2020 7:01:12 AM
Lol, good one! Sad, but true... (1)
CYDY CytoDyn Inc
09/01/2020 6:00:40 AM
PR out - https://www.cytodyn.com/ne (3)
CYDY CytoDyn Inc
09/01/2020 5:56:12 AM
Another Kevzara (sarilumab) trial f (2)
CYDY CytoDyn Inc
08/31/2020 10:41:15 AM
Agree that galidesivir looks 1000x (4)
CYDY CytoDyn Inc
08/31/2020 10:22:12 AM
More and more money getting thrown (1)
CYDY CytoDyn Inc
08/28/2020 6:47:55 PM
Agree with your take...
CYDY CytoDyn Inc
08/28/2020 5:01:18 PM
What a joke... remdesivir OKed for (1)
CYDY CytoDyn Inc
08/28/2020 4:39:02 PM
PR out - CC on September 2 https://
CYDY CytoDyn Inc
08/27/2020 2:44:49 PM
Has the protocol even been submitte
CYDY CytoDyn Inc
08/27/2020 1:51:58 PM
Fortuno has been here since the inc (18)
CYDY CytoDyn Inc
08/27/2020 12:13:30 PM
I agree... let's give it 2-3 more w (1)
CYDY CytoDyn Inc
08/23/2020 4:48:43 PM
"What I don’t understand is how t (4)
CYDY CytoDyn Inc
08/20/2020 3:55:11 PM
New PI interview https://www.youtub (4)
CYDY CytoDyn Inc
08/20/2020 12:21:24 PM
NASH study registered https://clini (11)
CYDY CytoDyn Inc
08/20/2020 4:52:35 AM
Another PR https://www.cytodyn.com/ (2)
CYDY CytoDyn Inc
08/20/2020 3:49:26 AM
PR out https://www.cytodyn.com/news
CYDY CytoDyn Inc
08/19/2020 4:33:55 PM
It is really a fascinating topic... (1)
CYDY CytoDyn Inc
08/19/2020 3:06:08 PM
I absolutely agree that we should b (3)
CYDY CytoDyn Inc
08/19/2020 2:47:20 PM
Yes (1)
CYDY CytoDyn Inc
08/19/2020 2:39:39 PM
Here's the thing: Very often (in ab (3)
CYDY CytoDyn Inc
08/19/2020 12:25:41 PM
Normally, yes. I don't trust FDA un
CYDY CytoDyn Inc
08/19/2020 12:02:32 PM
The sad reality is that it is just (5)
CYDY CytoDyn Inc
08/19/2020 11:53:33 AM
"It’s already been discussed that (3)
CYDY CytoDyn Inc
08/19/2020 9:19:31 AM
F.D.A.’s Emergency Approval of Bl (2)
CYDY CytoDyn Inc
08/18/2020 5:29:52 PM
I suspected price would crash after
CYDY CytoDyn Inc
08/17/2020 4:50:17 PM
True, but the two sites in Texas al (3)
CYDY CytoDyn Inc
08/17/2020 4:27:41 PM
Agree, Cap!
CYDY CytoDyn Inc
08/17/2020 4:19:25 PM
Enrollment pace is disappointing. O (5)
CYDY CytoDyn Inc
08/17/2020 6:19:07 AM
https://www.cytodyn.com/newsroom/p (3)
CYDY CytoDyn Inc
08/17/2020 6:00:52 AM
https://www.cytodyn.com/newsroom/p
CYDY CytoDyn Inc
08/16/2020 6:28:26 PM
Hm... good points... But in the end
CYDY CytoDyn Inc
08/16/2020 5:27:06 PM
Neither the 10-k nor the clinicaltr (2)
CYDY CytoDyn Inc
08/16/2020 3:28:11 PM
Generally speaking: as long as >=20 (3)
CYDY CytoDyn Inc
08/16/2020 3:14:33 PM
Enrollment ratio is 2:1. They misse
CYDY CytoDyn Inc
08/15/2020 9:07:23 AM
Obviously, if we score an approval (1)
CYDY CytoDyn Inc
08/15/2020 8:19:19 AM
They have asked for a meeting, but (4)
CYDY CytoDyn Inc
08/15/2020 6:22:52 AM
"During June 2020, the Company ente (2)
CYDY CytoDyn Inc
08/12/2020 5:03:54 PM
Could it be that reporting of enrol
CYDY CytoDyn Inc
08/11/2020 6:04:30 PM
Yes. Would be nice to hear that we
CYDY CytoDyn Inc
08/11/2020 5:50:31 PM
They would have had the CC anyway. (3)
CYDY CytoDyn Inc
08/11/2020 3:44:17 PM
https://www.cytodyn.com/newsroom/p
CYDY CytoDyn Inc
08/10/2020 9:23:03 AM
It's data from a compassionate use (1)
CYDY CytoDyn Inc
08/07/2020 9:03:00 AM
"Desperation and stupidity. Figure (13)
CYDY CytoDyn Inc
08/07/2020 1:39:42 AM
Yeah, I liked that too. Smart move. (7)
CYDY CytoDyn Inc
08/07/2020 1:18:19 AM
"Dr. Patterson, from most recent Yo
CYDY CytoDyn Inc
08/06/2020 5:40:52 PM
No, I wasn't saying this. Whether t (5)
CYDY CytoDyn Inc
08/06/2020 5:05:24 PM
If the p-value at n=170 isn't good (8)
CYDY CytoDyn Inc
08/06/2020 4:13:53 PM
Yeah, but he mentioned it afterward (1)
CYDY CytoDyn Inc
08/06/2020 3:49:38 PM
CYDY could ask for that, and at som
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • Reddit Investors: Join the Class Action Against Fraud Today
  • Investor Alert: Securities Fraud Class Action Lawsuit Against Hims & Hers
  • Perplexity's Success: Aravind Srinivas Challenges Tech Titans
  • Insights from Bill Ackman: Investing During Market Uncertainty
  • Berkshire Hathaway Faces Challenges Amidst Market Uncertainty
  • Unveiling Underrated Stocks to Watch for Future Growth
  • Revolutionizing Connectivity: The Future of Starlink Technology
  • Understanding Your Rights as a Simulations Plus, Inc. Investor
  • Shiba Inu Coin Flourishes as HashJ Introduces New Contracts
  • Recent Stock Insights: Key Players in the Market Breakdown
  • Risetcar's Autonomous Taxis Set to Transform Jakarta's Transport
  • Pan-Mass Challenge: Cyclists Unite for Groundbreaking Research
  • Bitcoin Swift Presale Enters New Phase with Innovative AI Rewards
  • Celebrating Financial Health: Global Impact Champions Awards Launch
  • Avast Emerges as the Top Choice for Antivirus Software
  • FAA Implements Changes to Helicopter Routes after Tragedy
  • Navigating High-Beta Stocks: Echoes of the Dot-Com Boom
  • Understanding the Real Dynamics Behind Portfolio Performance
  • Overview of Financière de Tubize’s Half-Year Performance
  • Financière de Tubize Unveils Promising Financial Results for 2025
  • Legal Actions from Shareholders: Insights on Sarepta and Petco
  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • SHARC Energy Advancing Financing with New Convertible Debentures
  • Important Class Action Update for Hims & Hers Health Investors
  • Class Action Lawsuit Emerges Against Flywire Corporation
  • Important Update for Sable Offshore Investors: Act Now
  • Class Action Notice for Neogen Investors: Key Details Inside
  • Tempus AI Faces Legal Challenges Following SEC Allegations
  • Replimune Group Faces Class Action: Key Insights for Investors
  • Neogen Corporation Investors Can Join Class Action Efforts
  • Key Actions for Luminar Technologies Investors Amid Class Action
  • Investors Urged to Act: RxSight Class Action Deadline Approaches
  • Sable Offshore Corp. Class Action: Important Actions for Investors
  • Protecting Your Rights Following Securities Claims with TRSG
  • Investors of Fiserv, Inc. Can Join Class Action for Losses
  • Kepler's K2 Humanoid Robot Revolutionizes Industrial Automation
  • Investor Rights Firm Investigates Potential Mergers and Sales
  • Investigating Stockholder Rights: Olo, Fubo, Arcadia, and Norfolk
  • RxSight Inc. Faces Class Action Lawsuit Over Misleading Claims
  • Spitzer Autoworld Elevates Customer Experience with New VIP Program
  • HashJ Launches New BTC Participation Contracts Amid Market Shift
  • Experience Vibrant Music Events at Great Park Live This Season
  • Explore OLIVE YOUNG's K-Beauty Innovations at KCON LA 2025
  • Discovering the Exceptional Growth of Gartner Stock Today
  • Investors of Sable Offshore Corp. Encouraged to File Claims
  • Senate Bill Secures Funding for OSHA and NIOSH - A Win for Safety
  • Arteris, Inc. Boosts Team with New Inducement Stock Awards
  • Investing in Ameriprise Financial: A 5-Year Review
  • Grupo Cox Makes Major Investment with Iberdrola Acquisition
  • First National Bank Alaska Announces Strong Q3 Dividend Strategy
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site